article Open AccessTop 1% cited
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
New England Journal of Medicine · 2011 · Vol. 364(19) · pp. 1817–1825
Thierry Conroy✉(Centre de Recherche en Automatique de Nancy)Françoise Desseigne(Centre Léon Bérard)Marc Ychou(CEA Valduc)Olivier Bouché(Centre Hospitalier Universitaire de Reims)Rosine Guimbaud(Institut Claudius Regaud)Y. Bécouarn(Institut Bergonié)Antoine Adenis(Centre Oscar Lambret)Jean‐Luc Raoul(Centre Eugène Marquis)S. Gourgou-Bourgade(CEA Valduc)Christelle de la Fouchardière(Centre Léon Bérard)Jaafar BennounaJean‐Baptiste Bachet(Hôpital Ambroise-Paré)Faiza Khemissa-Akouz(Centre Hospitalier de Perpignan)Denis Péré-Vergé(Hôpital de la Croix-Rousse)Catherine Delbaldo(Centre Hospitalier Universitaire Henri-Mondor)Eric Assénat(Hôpital Saint Eloi)Bruno Chauffert(Centre Georges François Leclerc)Pierre Michel(Université de Rouen Normandie)C. Montoto-Grillot(UniCancer Group)Michel Ducreux(Institut Gustave Roussy)
Abstract
International audience
Pancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsColorectal Cancer Treatments and StudiesFOLFIRINOXGemcitabineIrinotecanOxaliplatinMedicineOncologyRegimenPancreatic cancerInternal medicineChemotherapy
Citations
7,636
FWCI
135.04
field-weighted impact
References
37
Percentile
100%
vs. same field & year
Citations per year
Cited by
Pancreatic Cancer Chemoresistance to Gemcitabine
Cancers · 2017 · 445 citations
RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients
Oncotarget · 2015 · 318 citations
Recent progress in pancreatic cancer
CA A Cancer Journal for Clinicians · 2013 · 934 citations
The Pancreas Cancer Microenvironment
Clinical Cancer Research · 2012 · 1,296 citations
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2015 · 1,308 citations
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
New England Journal of Medicine · 2013 · 6,561 citations
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
World Journal of Gastroenterology · 2018 · 1,935 citations
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
Cancer Cell · 2012 · 2,074 citations
References
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Journal of Clinical Oncology · 1997 · 5,865 citations
Interpreting the significance of changes in health-related quality-of-life scores.
Journal of Clinical Oncology · 1998 · 2,890 citations
Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
BMC Cancer · 2008 · 431 citations
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary
Annals of Oncology · 2003 · 1,013 citations
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
JNCI Journal of the National Cancer Institute · 2000 · 15,689 citations
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
Journal of Clinical Oncology · 2007 · 3,845 citations
Cancer Statistics, 2010
CA A Cancer Journal for Clinicians · 2010 · 12,602 citations
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
JNCI Journal of the National Cancer Institute · 1993 · 15,705 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.